It's not just that the PSA didn't go down along with tumor and bone responses, it's that it actually skyrocketed (typically doubled or more). In all other prostate treatments I am aware of (except for Dendreon's) PSA was tightly linked to improvement.
I have no idea what this means, but I'll take actual improvement in tumors, mets and pain over a biomarker any day.